GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimi Health Corp (XCNQ:OPTI) » Definitions » EV-to-EBITDA

Optimi Health (XCNQ:OPTI) EV-to-EBITDA : -11.46 (As of May. 22, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Optimi Health EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Optimi Health's enterprise value is C$23.44 Mil. Optimi Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was C$-2.05 Mil. Therefore, Optimi Health's EV-to-EBITDA for today is -11.46.

The historical rank and industry rank for Optimi Health's EV-to-EBITDA or its related term are showing as below:

XCNQ:OPTI' s EV-to-EBITDA Range Over the Past 10 Years
Min: -11.46   Med: -6.06   Max: -2.46
Current: -11.46

During the past 5 years, the highest EV-to-EBITDA of Optimi Health was -2.46. The lowest was -11.46. And the median was -6.06.

XCNQ:OPTI's EV-to-EBITDA is ranked worse than
100% of 739 companies
in the Drug Manufacturers industry
Industry Median: 13.6 vs XCNQ:OPTI: -11.46

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-05-22), Optimi Health's stock price is C$0.215. Optimi Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was C$-0.030. Therefore, Optimi Health's PE Ratio (TTM) for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Optimi Health EV-to-EBITDA Historical Data

The historical data trend for Optimi Health's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimi Health EV-to-EBITDA Chart

Optimi Health Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24
EV-to-EBITDA
- -5.47 -3.32 -3.72 -5.35

Optimi Health Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Dec24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.72 -5.31 -5.36 -5.35 -11.04

Competitive Comparison of Optimi Health's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Optimi Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Optimi Health's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Optimi Health's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Optimi Health's EV-to-EBITDA falls into.


;
;

Optimi Health EV-to-EBITDA Calculation

Optimi Health's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=23.442/-2.046
=-11.46

Optimi Health's current Enterprise Value is C$23.44 Mil.
Optimi Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-2.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Optimi Health  (XCNQ:OPTI) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Optimi Health's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.215/-0.030
=At Loss

Optimi Health's share price for today is C$0.215.
Optimi Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.030.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Optimi Health EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Optimi Health's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Optimi Health Business Description

Traded in Other Exchanges
Address
21 Water Street, Suite 600, Vancouver, BC, CAN, V6B 1A1
Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.
Executives
Dane Nicholas Stevens Director, Senior Officer
Bryan Edward Safarik Director, Senior Officer
William John Ciprick Senior Officer
Jacob Frederick Safarik Director, Senior Officer
Jonathan Schintler Director
John James Wilson Director
Michael Alan Stier Director